SUMMARY At the end of a multifactorial cardiovascular preventive trial serum thiocyanate was measured in random samples of 1035 cases and 1087 controls. A cut-off point 0-45 mg/dl (77 6/,umol/l) gave a sensitivity of 82 1% among the cigarette smokers in the control group and a specificity of 91 0% among the non-smokers. When the intervention and control groups are compared in terms of self-reported smoking behaviour non-significant differences in mean thiocyanate concentration are observed for those who never smoked, ex-cigarette smokers, actual cigarette smokers, and in four different cigarette smoking categories. Our results fail to confirm the reported pessimistic views concerning the validity of self-reported smoking behaviour in subjects taking part in intervention trials.
It has been argued that self-reported smoking techniques have been described elsewhere.3 Thirty behaviour should be interpreted with caution, factories were paired according to type of industry, particularly when subjects are taking part in a and one member of each pair was randomly allocated controlled trial.' An objective evaluation of to the intervention group with the other serving as a self-reported smoking behaviour would be important control. There were 19 409 men aged 40-59 listed, of when differences between experimental and control whom 16 222 (83.7%) took part in the base-line groups are small and expressed in numbers of examination. In the intervention group-of 7398-all cigarettes smoked daily. subjects were initially screened for risk factors In the Belgian Heart Disease Prevention Project (systolic blood pressure, resting ECG, weight and significant differences in the percentage of smokers height, serum cholesterol concentration, and smoking as well as in the amount smoked was observed in a habits). In the control group of 8824, 10% of all group of high-risk subjects after two years of subjects in each factory were randomly selected to follow-up.2 No significant difference in the undergo the same initial examination as all the percentage of smokers was observed between total subjects in the intervention group; in the other 90% intervention and control groups, but the only an ECG at rest was recorded. For all the subjects self-reported number of cigarettes smoked daily was in the intervention group and for 10% of the total significantly lower in the intervention group control group who underwent the same thorough compared with the control group: consequently we initial examination, risk scores were established suspected that differences at end-screening, if any, based on the initial results. The 600 subjects belonging would be detectable only in the mean number of to the top 21% of the risk score distribution were cigarettes smoked daily. We : 0*5 ml serum were mixed with 2 ml 15% trichloroacetic acid and centrifuged for 10 minutes. An aliquot of the supernate (1.5 ml) was transferred to a glass-fitted tube; standards were prepared by mixing 0-3 ml KSCN solutions (0.1, 0-25, 0 5, 0 75, 1.0, and 1-25 mg SCN/dl) with 1-2 ml 15% trichloroacetic acid. The following reagents were then added suquentially to each tube: 0-2 ml saturated bromine water, 0-2 ml 4% As203 in 2% NaOH, 1-6 ml 1% benzidine 2 HC1 in water, and 2 ml pyridine. After 30 minutes optical density was read against blank at 525 mm. A serum sample measured in 27 different assays gave a mean ± SD of 0-61 ± 0-02 mg/dl (Interassay CV = 3.5%).
Results
The incidence of ex-smokers during the six years of the trial was almost identical in both the intervention (26-5%) and control (26-5%) groups; the incidence was slightly but not significantly higher among the high-risk subjects of the intervention group (30.9%) compared with the high-risk control group (28.0%).
The change between base-line and end-screening in the mean number of cigarettes smoked daily among subjects who smoked cigarettes at base-line (= Acigarettes/day) was calculated. No differences were observed in A cigarettes/day between total intervention and 10% random sample of the control group. Nevertheless a significant difference in A cigarettes/day was observed between the high-risk subjects of the intervention group compared with the high-risk control subjects ( In fig 2 the mean thiocyanate concentrations (and SEM) are given for non-smokers and for current cigarette smokers by number of cigarettes; a significant gradient is found with increasing numbers of cigarettes smoked; even smokers of one to five cigarettes a day show a significant higher mean thiocyanate concentration compared with nonsmokers. The correlation coefficient between thiocyanate concentrations and number of cigarettes smoked a day is 0-41.
When thiocyanate concentrations in ex-smokers are compared with those in current cigarette smokers the same difference and gradient are observed.
We evaluated the sensitivity and specificity of the technique in subjects of the control group, as it is In a sample of the multiple risk factor intervention trial 102 non-smokers and 162 smokers were followed up during one year with base-line and follow-up measurements of thiocyanate concentrations.13 The cigarette smokers were given an intervention programme consisting of 10 weekly or bi-weekly meetings of two hours' duration each.
Among the subjects who reported a decrease in numbers of cigarettes smoked the authors observed an increase of 75% in thiocyanate concentration per smoked cigarette. The authors suggest an individual titration to tobacco smoke or alternatively a false under-reporting of smoking behaviour that could be called a "social conforming behaviour." In their final report concerning risk factor modification the multiple risk factor intervention trial reported serum thiocyanate concentrations as measured, both in special intervention and usual care groups at entry and at 12, 24, 36, ane 48 months.14 Compared with thiocyanate concentrations for initial non-smokers those for cigarette quitters, both in the special intervention and usual care groups, were much higher. Thus while under-reporting appeared in both groups it was relatively more important in the special intervention group. The authors also question the sensitivity of the thiocyanate method for the detection of smoking reduction in participants who continue to smoke.
We did not perform serial thiocyanate measurements over time which hampers comparison with other studies. Nevertheless, our results fail to confirm the reported pessimistic views concerning the validity of self-reported smoking behaviour in subjects taking part in an epidemiological intervention trial. Indeed, both for ex-cigarette smokers as for subgroups of cigarette smokers no significant differences in thiocyanate concentrations were observed between intervention and control groups. Furthermore, in a subsample of smokers differences in mean number of cigarettes smoked between intervention and control groups were in parallel with significant differences in thiocyanate concentrations. It should be remembered, however, that due to a less aggressive and individualised prevention programme as compared with the multiple risk factor intervention trial study, the results at end-screening in terms of differences between intervention and control groups were weak. The soft intervention procedures perhaps did not induce a feeling of social conforming behaviour in the intervention subjects, hence their more "honest" self-reporting of smoking behaviour. 
